FDA Approves Improved Chest X-ray Technology

June 22, 2010 – Riverain Medical announced this week that the U.S. Food and Drug Administration (FDA) has granted approval for the newest version of the OnGuard Chest X-ray Computer-Aided Detection (CAD) technology. OnGuard identifies solitary pulmonary nodules that may represent early-stage lung cancer on an existing chest X-ray. This improved performance demonstrates a 73 percent reduction in false positive marks and 50 percent higher relative sensitivity compared to the original product. [1]

More than 200,000 Americans will be diagnosed with lung cancer this year. Only a small percentage of these patients will be diagnosed with lung cancer in the earliest stages when it is most treatable. When lung cancer is detected early, five-year survival rates triple. [2] Multiple studies demonstrate that OnGuard can detect 37 to 50 percent of lung cancers that were missed in the initial interpretation. [3, 4]

“Our published studies demonstrate that OnGuard can detect up to 50 percent of the lung cancers that were missed in the initial interpretation,” says Dr. Charles White, professor and vice chairman of radiology at the University of Maryland School of Medicine. “OnGuard provides physicians with a tool to help identify suspicious nodules in the lungs earlier.”

Also cleared by the FDA is SoftView, a new image enhancement technology that increases the clarity of chest X-rays by suppressing bone on the digital image. The software automatically provides a soft tissue image for every chest X-ray.

For more information: www.riverainmedical.com

References:
1. Riverain Medical Clinical Trial for U.S. FDA Submission
2. American Cancer Society Facts and Figures 2010
3. White, C.; Flukinger, T.; Jeudy, J. and Chen, J. (2009). “Use of a Computer-Aided Detection System to Detect Missed Lung Cancer at Chest Radiography.” Radiology. 252: 273-281.
4. Li, F.; Englemann, R.; Metz, C.; Doi, K. and MacMahon, H. (2008). “Lung Cancers Missed on Chest Radiographs: Results Obtained with a Commercial Computer-aided Detection Program.” Radiology. 246: 273-280.

 


Related Content

News | Radiation Dose Management

April 9, 2024 — Mirion Dosimetry Services, a Mirion Medical company, today announced commercial availability of its ...

Time April 09, 2024
arrow
News | Coronavirus (COVID-19)

March 21, 2024 — Artificial intelligence can spot COVID-19 in lung ultrasound images much like facial recognition ...

Time March 21, 2024
arrow
News | Coronavirus (COVID-19)

March 20, 2024 — SARS-CoV-2, the virus that causes COVID-19, can damage the heart even without directly infecting the ...

Time March 20, 2024
arrow
News | HIMSS

March 8, 2024 — DeepTek.ai, a leading medical imaging AI company, will showcase its groundbreaking US FDA-cleared chest ...

Time March 08, 2024
arrow
News | Artificial Intelligence

March 6, 2024 — Body Vision Medical, a leader in AI-driven, intraoperative imaging, announced the successful validation ...

Time March 06, 2024
arrow
News | Artificial Intelligence

February 29, 2024 — AIxSCAN, Inc., a Sunnyvale, CA-based developer of a next generation artificial intelligence (AI) ...

Time February 29, 2024
arrow
News | Artificial Intelligence

February 26, 2024 — DeepHealth, Inc., one of the leading providers in healthcare radiology informatics, has today ...

Time February 26, 2024
arrow
News | Radiology Imaging

February 23, 2024 — Can dual-energy tomosynthesis be performed portably? This is one of the topics to be discussed by KA ...

Time February 23, 2024
arrow
News | Artificial Intelligence

February 6, 2024 — Medical imaging AI innovator, Qure.ai, has received breakthrough device designation from the Food and ...

Time February 06, 2024
arrow
News | Artificial Intelligence

February 2, 2024 — DeepTek.ai, a leading provider of artificial intelligence (AI) solutions for medical imaging ...

Time February 02, 2024
arrow
Subscribe Now